18th March 2016 IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR Incruse®▼ Ellipta® (umeclidinium inhalation powder) Incruse®▼ Ellipta® 55 micrograms (umeclidinium bromide) manufactured by GSK is a dry powder for inhalation which was launched in the UK in July 2014. UKMI has…
Didn’t find what you were looking for? If you need to know more you can ask one of our experts for help. Ask a question